Since the increased AMH would impair the action of FSH and contribute to the FA of PCOS, this evidence has led us to hypothesise that there is a subgroup of women with PCOS who have the higher levels of AMH and who are the more resistant to CC treatment. This evidence concerns the gene BRD2 and polycystic ovary syndrome.